je.st
news
FDA: AstraZeneca's diabetes drug showed increased death risk
2015-04-11 13:08:02| Biotech - Topix.net
AstraZeneca PLC's type 2 diabetes drug Onglyza showed an increased risk of death in an analysis by U.S. regulators of a clinical trial on the heart effects of the treatment. Food and Drug Administration staff said their analysis of deaths in the trial suggested patients using Onglyza experienced "significant or near-significant" increases in death from all causes, not just heart problems.
Tags: death
increased
risk
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|